TGA Warns of Vision Risk From GLP-1 Drugs

TGA Australia GLP-1 drugs Ozempic Wegovy

Australia's Therapeutic Goods Administration issued a safety warning about a rare but serious eye disorder risk linked to GLP-1-based weight loss drugs including Ozempic and Wegovy. The alert notifies users of potential vision impairment as a side effect.

4 reports · 1 independentinternational · other

Claim audit

No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.

All coverage

TGA issues warning over rare eye disorder linked to Ozempic-like drugs

rss:abc-auinternational67d ago wire ×4 kagi ↗

The Therapeutic Goods Administration has issued a safety warning for a rare, but serious risk of vision impairment from taking GLP-1-based drugs such as Ozempic and Wegovy.

TGA issues warning over rare eye disorder linked to Ozempic-like drugs

rss:abc-au-topstoriesinternational67d ago echo kagi ↗

TGA issues warning over rare eye disorder linked to Ozempic-like drugs

stream:bsky-jetstreamother67d ago echo kagi ↗

this outlet adds: touching, shit, never, going, hugz, https, news, 2026

TGA issues warning over rare eye disorder linked to Ozempic-like drugs

stream:bsky-jetstreamother67d ago echo kagi ↗